Search
for
Sort by
Research 871–900 of 1000+
- A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Testosterone therapy for transgender men
- Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus
- Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review
- Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Testosterone therapy in women: Myths and misconceptions
- Increased androgen receptor messenger RNA in frontal-parietal hair follicles of women with androgenetic alopecia
- Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Hormone replacement therapy and the skin
- The role of androgen and androgen receptor in skin-related disorders
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Polygonum multiflorum extract support hair growth by elongating anagen phase and abrogating the effect of androgen in cultured human dermal papilla cells
- Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy
- Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
- Exploring the therapeutic potential of metformin in polycystic ovary syndrome: focusing on hyperandrogenism in a sample of Iraqi women
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Advances In Mesenchymal Cell Therapy In Dermatology And Aesthetic Medicine
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- K channel therapeutics at the bedside